NCT01787565

Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 86 (actual)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this investigation is to determine whether the use of painPREMIER will significantly improve function in patients with low back pain in an occupational health clinical setting. painPREMIER is a tool that assists clinicians in the accurate diagnosis of back pain and associated problems in order to treat them most effectively.

Detailed description

Patients presenting at feeder sites to be referred to low back pain clinic and assessed for eligibility A decision was made to terminate this study on 09 OCT 2013. The study was terminated for operational/business reasons. This study was not terminated for reasons of safety or efficacy.

Conditions

• Back Pain

Interventions

Type	Name	Description
OTHER	painPREMIER cohort	Low back pain patients prospectively recruited during the study period and managed with painPREMIER.
OTHER	Control cohort	A matched group of low back pain patients not managed with painPREMIER.

Timeline

• Start date: 2013-01-01
• Primary completion: 2014-01-01
• Completion: 2014-01-01
• First posted: 2013-02-08
• Last updated: 2016-04-06

Locations

1 site across 1 country: Finland